A parent emailed us last monsoon with a photograph of two tubes on her kitchen counter. Both said clinically tested. One cost ₹280, the other ₹740. Her question was blunt: "Is the expensive one tested more?"
Maybe. Or not at all. "Clinically tested" is not a protected term in India — it describes that a test happened, not what the test found, who it was done on, or whether the finished product was even in the tube. A brand can run a 48-hour patch test on 25 adult volunteers, tick the box, and print the phrase in the same font as a brand that ran a four-week supervised study on infants. Same two words on both packs. Behind them, two completely different invoices.
I run the brand side of Janma, which means I'm the one who signs those invoices. So this comes from the paying end of the process — part of our complete guide to how Janma is built. What a label can tell you, and where it goes quiet.
At a glance
- "Clinically tested" only tells you a test was run. Not on whom, not for how long, not with what result.
- The three common tests — patch test, dermatologist-supervised safety, and in-vivo efficacy — differ enormously in cost, rigour and what they prove.
- Efficacy claims ("reduces the look of redness") require a different, harder study than safety claims ("non-irritating").
- Ingredient-level data is not product-level data. A brand can cite a supplier's study for an active that makes up 0.5% of the formula.
- Ask one question: tested on whom, and what changed? A brand with a real study will answer in a sentence. A brand without one will send you a certificate.
What does "clinically tested" legally mean in India?
Cosmetics here sit under the Drugs and Cosmetics Act and the Cosmetics Rules, 2020. Those rules govern manufacturing licences, labelling, safety and prohibited claims. What they don't do is define "clinically tested" as a term of art with a minimum protocol. No rule says the study must run 28 days. Or use 30 subjects. Or include a single baby.
Legally, then, the phrase is a soft descriptor. Commercially it's a trust signal, read at speed by a parent who has a crying infant in one arm and a chemist waiting. The distance between those two things is wide. Being candid about my own industry: a fair amount of marketing has moved into it.
The three tests behind the same two words
Nearly every "clinically tested" claim on an Indian baby product traces back to one of three studies. Swapping one for another is not a technicality. The price gap alone runs into lakhs.
| What was run | What it actually shows | Typical subjects | What it does NOT show |
|---|---|---|---|
| Patch test (occlusive, 24–48 hrs) | The product didn't irritate skin under a sealed patch in a short window | Adult volunteers, usually forearm or back | Nothing about babies, real-world use, or whether it works |
| Dermatologist-supervised safety / "dermatologically tested" | A dermatologist observed use and recorded no significant adverse reactions | Adults, sometimes children; sample sizes vary widely | Efficacy. "Didn't cause a problem" ≠ "solved a problem" |
| In-vivo efficacy study | A measured, observed change on real skin over a defined period, with a defined usage protocol | The actual intended user — including infants, under paediatric consent | That every child will respond identically; individual skin varies |
| Ingredient-supplier study (cited by the brand) | That an ingredient did something, usually at a set concentration | Often lab models or adult panels | That the finished product contains a meaningful dose of it |
That fourth row is the one I'd flag hardest, and the one parents almost never think about. A supplier's dossier for, say, a barrier lipid may show a lovely result at 3% concentration. A brand can put in 0.1% and still, technically, talk about the ingredient's published science. The tube won't tell you which. We wrote separately about what "dermatologically tested" actually means, because that phrase gets stretched the same way.
Why baby skin makes this more than semantics
A baby's skin is 20-30% thinner than an adult's. Less mature barrier. Higher surface-area-to-weight ratio. Loses water faster. An adult forearm, sealed under a patch for two days in an air-conditioned lab, is a poor stand-in for a six-month-old's cheek through a Nagpur summer.
Up to ~48.6% of babies experience atopic-type skin issues. That is not a niche subgroup. That is close to half the babies in the country, each with a parent standing at a counter, reading claims.
What we chose to test, and what it cost us
When we planned our testing, the cheap version was sitting right there. A patch panel, a certificate, done inside a fortnight. We went the other way. It pushed the launch back by months and I had to explain that to people who were counting on the original date.
Our in-vivo work looked at what a parent actually cares about. On a 12-month-old subject, applied twice daily, we recorded visible improvement in the look of diaper-area redness in 7 days. On 24- and 36-month subjects, we saw visibly calmer skin in as little as 1 day. Separately, in lab study, we measured increased Keratin-10 and Filaggrin expression — proteins involved in building the skin's own barrier. Which is why we say a formulation helps support the skin barrier, and then stop talking.
Read those sentences again. The look of redness. Helps support. The subject's age. The frequency. Nowhere do they say cured, healed or treated, because a cosmetic doesn't do those things, and a brand that tells you otherwise is making a promise it cannot back.
We can run this work because we make our own formulations in our own GMP-certified facility in Nagpur. White-label works differently. The formula belongs to a contract manufacturer who sells versions of it to several brands at once, and paying for a bespoke study on a formula you don't own is a strange business decision. Most brands, rationally, don't make it. That's a big part of why we manufacture rather than outsource. You can't really separate the two questions.
So which tube do you buy?
Setting my own brand aside: price tells you almost nothing, and neither does the phrase "clinically tested" on its own. Specificity is the signal.
If a pack names the subjects, the duration, the frequency of use and the exact outcome, then somebody ran a study and had to write the numbers down. If it offers the phrase plus a stock photograph of a doctor holding a clipboard, it's decoration. Given the ₹280 tube that says "in-vivo tested, 4 weeks, 30 infant subjects" and the ₹740 tube that says "clinically tested" and nothing more, I'd take the ₹280 one to the counter without pausing.
Do this tonight: a two-minute label audit
- Find the claim. Is there a number attached — days, subjects, ages, frequency? No number, no study you can evaluate.
- Check whether the claim is about safety ("non-irritating", "hypoallergenic") or efficacy ("reduces the look of redness"). They're not the same evidence.
- Look for the word "in-vivo" or "in-use". "In-vitro" means lab dish, not skin.
- Read who it was tested on. If it doesn't say babies, assume adults.
- Check the manufacturing line on the back. A GMP-certified, FDA-licensed cosmetic manufacturer with its own facility can be asked questions and can answer them.
- Email the brand one line: "What was the study protocol behind this claim?" Watch what comes back, and how fast.
When to see a doctor
No amount of testing on a label replaces a paediatrician. See a doctor if your baby's skin is broken, weeping, blistered or bleeding; if redness spreads, comes with fever, or doesn't settle within a few days of gentle care; if there are pus-filled spots or a bright, satellite-speckled rash that may be fungal; or if a new product causes swelling, hives or distress. Stop the product, photograph the skin, and take both to the appointment. Under three months old, call sooner rather than later.
The uncomfortable bit
"Clinically tested" is everywhere because it's cheap to print and it lands on people who are exhausted and frightened. I'd rather the term were regulated with a minimum protocol. It would cost brands like ours nothing — we already do the work — and it would cost the box-tickers a great deal. Until that happens, the checking falls to you, in a chemist's shop, at the end of a long day. That isn't fair, and I don't have a way around it.
What I can give you is one question to carry instead of a list. Tested on whom, and what changed? Ask it. The rest follows.
In summary
- "Clinically tested" is unregulated as a phrase — it confirms a test happened, not what it found or on whom.
- Patch tests, dermatologist-supervised safety studies and in-vivo efficacy studies prove very different things at very different costs.
- Treat safety claims ("non-irritating") and efficacy claims ("reduces the look of redness") as separate kinds of evidence.
- Ignore price as a proxy for rigour and judge specificity instead: subjects, ages, duration, frequency, measured outcome.
- Email the brand one question — "tested on whom, and what changed?" — and let the answer or the silence decide it.
Frequently asked questions
Is "clinically tested" the same as "clinically proven"?
No. "Clinically tested" means a test was conducted — it says nothing about the result. "Clinically proven" implies a demonstrated outcome, and is a much stronger claim that should be backed by a specific study with named subjects, duration and measured endpoints. In practice, many products carry the first phrase while implying the second. Ask which study, on whom, and what changed.
Does "clinically tested" mean the product was tested on babies?
Not necessarily. Many baby products carry the phrase on the strength of patch tests or dermatologist-supervised studies conducted on adult volunteers. Since a baby's skin is 20-30% thinner than an adult's, that is a weak proxy. If a brand tested on infants, it will almost always say so explicitly, including the subject ages. Silence usually means adults.
What does "in-vivo tested" mean?
In-vivo means the test was conducted on living human skin, under a defined usage protocol, rather than on a lab model or cell culture. In-vitro means the opposite — a dish or a reconstructed skin model. In-vivo studies on the intended age group are the most meaningful evidence a cosmetic brand can offer, and the most expensive to run.
Can a brand cite an ingredient's clinical study as its own?
Yes, and it happens often. An ingredient supplier's data may show an effect at a specific concentration; a brand can include a much smaller amount and still reference the ingredient's published science. Nothing on the pack reveals the actual percentage. Ingredient-level evidence is not finished-product evidence — only a study on the actual formulation is.
Is a more expensive baby product better tested?
There is no reliable relationship between price and testing depth. Price reflects packaging, marketing spend, retail margin and ingredient cost far more than clinical investment. Judge on specificity instead: a claim that names the subjects, the duration, the frequency of application and the measured outcome came from a real study. A bare phrase did not.
What should I ask a baby brand about its testing?
One question does most of the work: "What was the protocol behind this claim — how many subjects, what ages, how long, applied how often, and what was measured?" A brand that ran the study can answer in a sentence. A brand that bought a certificate will send you the certificate. The shape of the reply tells you what you need.
